Koninklijke Philips (PHG) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Koninklijke Philips (PHG) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.82 Bn | 126.34 Bn | 4.50 Bn |
| 3 | Medtronic | 120.34 Bn | 111.12 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.41 Bn | 73.88 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.56 Bn | 48.31 Bn | 1.35 Bn |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.73 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 455.61% |
| Mar 31, 2026 | 416.22% |
| Dec 31, 2025 | 269.49% |
| Sep 30, 2025 | 341.00% |
| Jun 30, 2025 | 311.12% |
| Mar 31, 2025 | 414.95% |
| Dec 31, 2024 | -251.87% |
| Sep 30, 2024 | 203.83% |
| Jun 30, 2024 | 334.22% |
| Mar 31, 2024 | -49.76% |
| Dec 31, 2023 | -51.53% |
| Sep 30, 2023 | -22.89% |
| Jun 30, 2023 | -37.53% |
| Mar 31, 2023 | -52.66% |
| Dec 31, 2022 | -1,441.87% |
| Sep 30, 2022 | -34.40% |
| Jun 30, 2022 | -21.01% |
| Mar 31, 2022 | -1,382.60% |
| Dec 31, 2021 | -4.64% |
| Sep 30, 2021 | 1,330.35% |